spanning from 2005 to October 2023 utilized the Food and Drug Administration Adverse Event Reporting System (FAERS) to investigate patterns of suicidality associated with GLP-1 RA usage
If you meet certain qualifications, you may be able to get GLP-1s at low or no cost for a period of time
From an aesthetic perspective, this matters because: GLP-1 RAs influence body composition, reducing lean mass, which might alter diffusion or uptake of injectables They impact systemic metabolism which may alter the pharmacokinetics or pharmacodynamics of other drugs As more patients on GLP-1 therapy request cosmetic injectables, including botulinum toxin, the potential for interaction becomes clinically relevant
The symptoms often come on suddenly and can include: Severe, persistent pain, usually on the lower left side of the abdomen
If a meal works, repeat it
This can make the overall treatment plan more comfortable and effective for the patient